Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Stepanova

Showing results (111-120 of 242) with videos related to

Pageof 25
Sort By:
Journal of Clinical and Experimental Hepatology|May 30, 2023
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United StatesZobair M Younossi, James M Paik, Linda Henry, et al.
The Journal of Infectious Diseases|January 14, 2015
Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2017
A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLDZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2016
Direct and Indirect Economic Burden of Chronic Liver Disease in the United StatesMaria Stepanova, Leyla De Avila, Mariam Afendy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2009
Independent predictors of fibrosis in patients with nonalcoholic fatty liver diseaseNoreen Hossain, Arian Afendy, Maria Stepanova, et al.
Diabetes Research and Clinical Practice|December 15, 2024
Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver diseaseZobair M Younossi, J Michael Estep, Sean Felix, et al.
Hepatology (Baltimore, Md.)|January 29, 2025
Prevalence and predictors of cirrhosis and portal hypertension in the United StatesZobair M Younossi, Leyla de Avila, Andrei Racila, et al.
Journal of Viral Hepatitis|December 30, 2023
The impact of hepatitis B and C positive serologies on the outcomes of non-hepatic solid organ transplantation in the United StatesSaleh A Alqahtani, Maria Stepanova, Reem Al Shabeeb, et al.
Diabetes Care|September 25, 2023
Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplantations in the U.S.: Data From a National RegistryMaria Stepanova, Ameeta Kumar, Pamela Brandt, et al.
Scandinavian Journal of Gastroenterology|December 1, 2010
Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)Noreen Hossain, Maria Stepanova, Arian Afendy, et al.
Pageof 25

Showing results (111-120 of 242) with videos related to

Sort By:
Pageof 25
Journal of Clinical and Experimental Hepatology|May 30, 2023
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United StatesZobair M Younossi, James M Paik, Linda Henry, et al.
The Journal of Infectious Diseases|January 14, 2015
Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Mark Sulkowski, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2017
A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLDZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2016
Direct and Indirect Economic Burden of Chronic Liver Disease in the United StatesMaria Stepanova, Leyla De Avila, Mariam Afendy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2009
Independent predictors of fibrosis in patients with nonalcoholic fatty liver diseaseNoreen Hossain, Arian Afendy, Maria Stepanova, et al.
Diabetes Research and Clinical Practice|December 15, 2024
Type 2 diabetes and the minor allele of PNPLA3 consistently identify high-risk metabolic dysfunction associated steatotic liver diseaseZobair M Younossi, J Michael Estep, Sean Felix, et al.
Hepatology (Baltimore, Md.)|January 29, 2025
Prevalence and predictors of cirrhosis and portal hypertension in the United StatesZobair M Younossi, Leyla de Avila, Andrei Racila, et al.
Journal of Viral Hepatitis|December 30, 2023
The impact of hepatitis B and C positive serologies on the outcomes of non-hepatic solid organ transplantation in the United StatesSaleh A Alqahtani, Maria Stepanova, Reem Al Shabeeb, et al.
Diabetes Care|September 25, 2023
Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplantations in the U.S.: Data From a National RegistryMaria Stepanova, Ameeta Kumar, Pamela Brandt, et al.
Scandinavian Journal of Gastroenterology|December 1, 2010
Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)Noreen Hossain, Maria Stepanova, Arian Afendy, et al.
Pageof 25